Rubella Vaccine

A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed)

Also Known As:

Networked: 464 relevant articles (11 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Centers for Disease Control and Prevention (CDC): 12 articles (06/2015 - 02/2000)
2.	Reef, Susan: 5 articles (09/2011 - 01/2005)
3.	Rota, Paul A: 4 articles (08/2015 - 03/2008)
4.	Poland, Gregory A: 4 articles (11/2014 - 02/2007)
5.	Ovsyannikova, Inna G: 4 articles (11/2014 - 02/2007)
6.	Bedford, Helen: 4 articles (11/2013 - 03/2004)
7.	Andrews, Nick: 4 articles (04/2011 - 02/2009)
8.	Kolasa, Maureen: 3 articles (08/2015 - 04/2006)
9.	Jacobson, Robert M: 3 articles (07/2014 - 02/2007)
10.	Jacobsen, Steven J: 3 articles (04/2014 - 12/2012)

Related Diseases

1.	Measles 08/01/2015 - "In Catalonia, since 1988 all children are given two doses of measles and rubella vaccine with high levels of vaccination coverage. " 11/01/2014 - "These results are the first to indicate that there are SNP associations in common across measles and rubella vaccine immune responses and that SNPs from multiple genes involved in innate and adaptive immune response regulation may contribute to the overall human antiviral response. " 11/01/2014 - "We also identified associations between individual SNPs in the IFNAR2 and TLR4 genes that were associated with IFN-γ secretion for both measles and rubella vaccine-specific immune responses. " 09/01/2011 - "Estimated national coverage with measles-rubella vaccine was 79.2% (95% confidence interval, 77.6%-80.7%), ranging from 90.2% in Nord-Ouest Department to 70.0% in Cite Soleil Metropolitan Area. " 09/01/2011 - "Measles-rubella vaccine was introduced into the country's routine childhood immunization schedule after the campaign. "
2.	Mumps 09/01/2014 - "Though the move to introduce rubella vaccine in to the UIP is laudable, the decision to overlook mumps seems inexplicable and illogical. " 09/01/2001 - "National and local pilot programmes did not succeed to promote vaccination in countees with a low measle-mumps-rubella vaccine coverage. " 03/01/1999 - "In both groups, more than 90% of infants showed an immune response to the mumps and rubella vaccine strains at 14 months of age. " 06/01/1973 - "Occurrence following combined mumps-rubella vaccine." 07/01/1997 - "Eighty-three percent of those who thought the efficacy of measles, mumps, and rubella vaccine would not be affected by a URI recommended vaccination vs only 8% of physicians who thought efficacy would decrease (P < .001). "
3.	Rubella (German Measles) 07/01/1983 - "These results indicate that rubella vaccine is highly effective in preventing clinical rubella and do not support proposals for routine revaccination." 12/12/2014 - "Among the mothers of infants with confirmed CRS none had received a rubella vaccine in the past and 88.4% gave a history of rubella contact during the pregnancy under study. " 12/17/2013 - "A rubella outbreak investigation and BRD-II strain rubella vaccine effectiveness study, Harbin city, Heilongjiang province, China, 2010-2011." 01/01/2013 - "However, in order for research to support the global expansion of rubella vaccination and the drive towards rubella elimination and eradication, additional studies are required in low-income countries, to tackle methodological limitations, and to determine the most cost-effective programmatic strategies for increased rubella vaccine coverage." 12/14/2012 - "To determine the age specific immunity profile for rubella from three discrete study populations in Papua New Guinea, and to inform policy regarding the possible introduction of rubella vaccine. "
4.	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 01/01/2014 - "Epidemiological data about congenital rubella syndrome (CRS) are scarce and rubella vaccine is not yet included in the childhood immunization schedule in Sudan. " 01/01/2013 - "Since the introduction of the Rubella vaccine in 1969, prevalence of congenital Rubella syndrome (CRS) has greatly declined in the United States. " 06/01/2012 - "Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India." 09/01/2011 - "None of the infants infected with rubella vaccine virus was born with congenital rubella syndrome. " 09/01/2011 - "In most developing countries, rubella vaccine has not been included in the Expanded Programme on Immunization because of lack of information on the burden of disease caused by rubella virus, increased cost associated with adding rubella vaccine, and the concern that if high vaccine coverage cannot be achieved and maintained, the risk of congenital rubella syndrome (CRS) may increase. "
5.	Infection 10/01/2010 - "Further studies are warranted to confirm whether chronic HBV infection, especially that acquired by vertical transmission, may impair the immune response to rubella vaccine or natural infection throughout the reproductive age." 02/01/2012 - "The effective number of infections remained constant until 2007, and along with the introduction of rubella vaccine into the national immunization program, although the circulation of cluster 1 viruses has not been interrupted, some viral lineages have disappeared, and the epidemic started a decline that led to a decrease in the effective population size. " 05/01/2000 - "This observation constitutes the first unequivocal documented case of rubella vaccine virus related to persistent fetal infection." 05/01/2000 - "Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy." 03/01/1976 - "Sera from 185 pregnant women, 200 children suspect of congenital infection, 15 mothers of intrauterin infected children, and 32 cases of rubella vaccine-induced immunity control were studied. "

Related Drugs and Biologics

1.	Measles Vaccine
2.	Chickenpox Vaccine (Vaccine, Varicella)
3.	Immunoglobulins (Immunoglobulin)
4.	6-Mercaptopurine (Mercaptopurine)
5.	Methotrexate (Mexate)
6.	Ibuprofen (Motrin)
7.	Vaccines
8.	Hepatitis B Vaccines (Hepatitis B Vaccine)
9.	Antibodies
10.	Tetanus Toxoid (Vaccine, Tetanus)

Related Therapies and Procedures

1.	Jet Injections
2.	Transplantation (Transplant Recipients)
3.	Immunotherapy
4.	Highly Active Antiretroviral Therapy (HAART)
5.	Transplants (Transplant)